South Jordan, UT, United States
South Jordan, UT, United States

Time filter

Source Type

News Article | December 5, 2016
Site: www.businesswire.com

WALTHAM, Mass.--(BUSINESS WIRE)--Verscend Technologies, Inc. (Verscend), a leader in data-driven healthcare solutions, today announced that Joe Driscoll has joined the company as chief financial officer (CFO). Driscoll is responsible for the overall financial management of Verscend, with a focus on managing growth and maximizing profitability through operational improvements. “Joe has significant leadership experience helping both public and private technology companies successfully manage and realize their financial goals,” said Dr. Emad Rizk, CEO of Verscend. “As Verscend continues to be at the forefront of the evolving healthcare industry, Joe will guide our team to continued financial success and support all of our internal groups to drive profitability throughout the organization.” Prior to joining Verscend, Driscoll was the CFO of PC Connection, Inc. (NASDAQ: CNXN) and was responsible for accounting, budgeting, and forecasting; investor relations; treasury; tax; internal audit; and SEC reporting activities for the publicly traded IT service provider. Driscoll profitably managed the company’s growth over the last four years. Before his time at PC Connection, Driscoll held CFO and senior finance positions at Summer Infant, Inc. (NASDAQ: SUMR); ACT Electronics; Staples, Inc. (NASDAQ: SPLS); and Safety 1st. “I look forward to leveraging my financial expertise and leadership experience to achieve our business goals,” said Driscoll. “Verscend is poised for tremendous growth in the healthcare analytics space, and I will help manage that growth successfully.” Verscend Technologies (formerly Verisk Health) drives better healthcare outcomes through data analytics. Our payment accuracy, revenue integrity, risk assessment and stratification, and quality improvement solutions help organizations utilize their data so they can efficiently and cost-effectively succeed in the new era of healthcare. Learn more at www.verscend.com.


— The report "Accountable Care Solutions Market by Product & Service (EHR, Healthcare Analytics, HIE, RCM, CDSS, Population Health, Claims Management, Care Management), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer) - Global Forecast to 2021", The accountable care solutions market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 16.6% between 2016 and 2021 to reach USD 18.86 Billion by 2021. The growth in this market is mainly attributed to factors such as increasing government initiatives, implementation of initiatives to shift the burden of financial risk from payers to healthcare providers, growing need to curb healthcare costs and advancing IT and big data capabilities. The global accountable care solutions market is segmented on the basis of product and service, delivery mode, end users and regions. Based on product and service, the global accountable care solutions market is segmented into healthcare provider solutions, healthcare payer solutions and services. In 2015, healthcare provider solutions accounted for the largest share of the accountable care solutions market covers electronic health/medical records, healthcare analytics, revenue cycle management, patient engagement solutions, population health management solutions, care management solutions, healthcare it integration systems, healthcare information exchange and clinical decision support systems. This segment is also expected to witness the highest growth in the next five years. The growing need to improve the profitability of healthcare operations and government initiatives for eHealth implementation to improve the quality of care delivered to patients & curtail healthcare costs are the major drivers of market growth. The services segment is further classified into support & maintenance services, implementation services, consulting services, training & education services. Furthermore, on the basis of end users, the market is classified into healthcare providers and healthcare payers. The healthcare providers end user segment accounted for the largest share of accountable care solutions market. The growing need to improve the profitability of healthcare operations and government initiatives to improve the quality of care delivered to patients & curtail the soaring cost of healthcare are some of the factors driving the adoption of accountable care solutions among providers. In 2015, North America was the major market for accountable care solutions product and service, followed by Europe and Asia-Pacific. The highest market share of North America and European regions is primarily attributed to the presence and expansion of major healthcare IT companies through acquisitions which has improved the accessibility of accountable care solutions products and services in this region. However, Asia-Pacific and Latin American regions provide wide scope for the accountable care solutions market growth. This is mainly attributed to the continuous efforts of Asian economies toward the development of the healthcare sector in this region. These economies have modified regulations and monitored the implementation of procedures, policies, and guidelines to promote innovation and commercialization. This is attracting many homegrown entrepreneurs as well as global leaders to the region. The increasing number of hospitals, academic institutions, government focus to implement information technology in healthcare and improving healthcare infrastructure propel the market for accountable care solutions. Cerner Corporation (U.S.), IBM Corporation (U.S.), Aetna, Inc. (U.S.) and Epic Systems Corporation (U.S.) held the major share of the accountable care solutions market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are UnitedHealth Group (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), ckesson Corporation (U.S.), Verisk Health (U.S.), Zeomega, Inc. (U.S.), eClinicalWorks, Inc. (U.S.) and NextGen Healthcare (U.S.). For more information, please visit http://www.marketsandmarkets.com/pdfdownload.asp?id=229274233


Global Population Health Management (PHM) Market, by Solution Software, Services (Consulting, Implementation, Training, Post Sales Maintenance), by Deployment (Web-based, Cloud-based, on Premise), by End-User (Healthcare Providers, Healthcare Payers, Private Employers, Government Organizations), by Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022. Dallas, TX, October 30, 2016 --( The market is segmented on the basis of solution, deployment, end-user and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-population-health-management-phm-market-trends-and-forecast-to-2022/. On the basis of solution, the Population Health Management (PHM) market is segmented into software and services. Based on services, the market is segmented into consulting, implementation, training and, post sales maintenance. Based on deployment, the market is segmented into Web-based, Cloud-based, On Premise. Based on end user, the market is segmented into healthcare providers, payers, private employers and government organizations. Based on geography, the market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. Read more: http://databridgemarketresearch.com/reports/global-population-health-management-phm-market-trends-and-forecast-to-2022/. Global Population Health Management (PHM) market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. The global players operating in this market are McKesson Corporation, ZeOmega Inc., Verisk Health Inc., Forward Health Group, Health Catalyst LLC, Athenahealth, Inc., Cerner Corporation, Medecision, Xerox Corporation, Allscripts, Inc., Fonemed Haiti SA, WellCentive, Inc., i2i Population Health, Conifer Health Solutions, LLC, GE Healthcare, Health Business Intelligence Corp, IBM Corporation, QSI Management, LLC, i2i Systems, Inc., OptumHealth, Inc., and Healthagen, LLC among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, October 30, 2016 --( PR.com )-- The market for Population Health Management (PHM) Market is expected to reach USD 41.6 billion by 2022, growing at 19.6% during the forecast years to 2022.The market is segmented on the basis of solution, deployment, end-user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-population-health-management-phm-market-trends-and-forecast-to-2022/.On the basis of solution, the Population Health Management (PHM) market is segmented into software and services. Based on services, the market is segmented into consulting, implementation, training and, post sales maintenance.Based on deployment, the market is segmented into Web-based, Cloud-based, On Premise.Based on end user, the market is segmented into healthcare providers, payers, private employers and government organizations.Based on geography, the market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.Read more: http://databridgemarketresearch.com/reports/global-population-health-management-phm-market-trends-and-forecast-to-2022/.Global Population Health Management (PHM) market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.The global players operating in this market are McKesson Corporation, ZeOmega Inc., Verisk Health Inc., Forward Health Group, Health Catalyst LLC, Athenahealth, Inc., Cerner Corporation, Medecision, Xerox Corporation, Allscripts, Inc., Fonemed Haiti SA, WellCentive, Inc., i2i Population Health, Conifer Health Solutions, LLC, GE Healthcare, Health Business Intelligence Corp, IBM Corporation, QSI Management, LLC, i2i Systems, Inc., OptumHealth, Inc., and Healthagen, LLC among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


Wiseguyreports.Com Adds “Population Health Management -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies Population Health Management in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Request for Sample Report @ https://www.wiseguyreports.com/sample-request/743896-global-population-health-management-market-professional-survey-report-2016 By types, the market can be split into Type I Type II Type III By Application, the market can be split into Application 1 Application 2 Application 3 By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Population Health Management Market Professional Survey Report 2016 1 Industry Overview of Population Health Management 1.1 Definition and Specifications of Population Health Management 1.1.1 Definition of Population Health Management 1.1.2 Specifications of Population Health Management 1.2 Classification of Population Health Management 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Applications of Population Health Management 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Population Health Management 8.1 Allscripts Healthcare 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Type I 8.1.2.2 Type II 8.1.2.3 Type III 8.1.3 Allscripts Healthcare 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Allscripts Healthcare 2015 Population Health Management Business Region Distribution Analysis 8.2 Cerner 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Type I 8.2.2.2 Type II 8.2.2.3 Type III 8.2.3 Cerner 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Cerner 2015 Population Health Management Business Region Distribution Analysis 8.3 Conifer Health 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Type I 8.3.2.2 Type II 8.3.2.3 Type III 8.3.3 Conifer Health 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Conifer Health 2015 Population Health Management Business Region Distribution Analysis 8.4 Explorys 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Type I 8.4.2.2 Type II 8.4.2.3 Type III 8.4.3 Explorys 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Explorys 2015 Population Health Management Business Region Distribution Analysis 8.5 Health Catalyst 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Type I 8.5.2.2 Type II 8.5.2.3 Type III 8.5.3 Health Catalyst 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Health Catalyst 2015 Population Health Management Business Region Distribution Analysis 8.6 Healthagen 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Type I 8.6.2.2 Type II 8.6.2.3 Type III 8.6.3 Healthagen 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Healthagen 2015 Population Health Management Business Region Distribution Analysis 8.7 I2i Systems 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Type I 8.7.2.2 Type II 8.7.2.3 Type III 8.7.3 I2i Systems 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 I2i Systems 2015 Population Health Management Business Region Distribution Analysis 8.8 Mckesson 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Type I 8.8.2.2 Type II 8.8.2.3 Type III 8.8.3 Mckesson 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Mckesson 2015 Population Health Management Business Region Distribution Analysis 8.9 Phytel 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Type I 8.9.2.2 Type II 8.9.2.3 Type III 8.9.3 Phytel 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Phytel 2015 Population Health Management Business Region Distribution Analysis 8.10 Verisk Health 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Type I 8.10.2.2 Type II 8.10.2.3 Type III 8.10.3 Verisk Health 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Verisk Health 2015 Population Health Management Business Region Distribution Analysis 8.11 Wellcentive 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.2.1 Type I 8.11.2.2 Type II 8.11.2.3 Type III 8.11.3 Wellcentive 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 Wellcentive 2015 Population Health Management Business Region Distribution Analysis For more information, please visit https://www.wiseguyreports.com/sample-request/743896-global-population-health-management-market-professional-survey-report-2016


News Article | November 15, 2016
Site: www.newsmaker.com.au

Wiseguyreports.Com Adds “Population Health Management -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies Population Health Management in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering By types, the market can be split into Type I Type II Type III By Application, the market can be split into Application 1 Application 2 Application 3 By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Population Health Management Market Professional Survey Report 2016 1 Industry Overview of Population Health Management 1.1 Definition and Specifications of Population Health Management 1.1.1 Definition of Population Health Management 1.1.2 Specifications of Population Health Management 1.2 Classification of Population Health Management 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Applications of Population Health Management 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Population Health Management 8.1 Allscripts Healthcare 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Type I 8.1.2.2 Type II 8.1.2.3 Type III 8.1.3 Allscripts Healthcare 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Allscripts Healthcare 2015 Population Health Management Business Region Distribution Analysis 8.2 Cerner 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Type I 8.2.2.2 Type II 8.2.2.3 Type III 8.2.3 Cerner 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Cerner 2015 Population Health Management Business Region Distribution Analysis 8.3 Conifer Health 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Type I 8.3.2.2 Type II 8.3.2.3 Type III 8.3.3 Conifer Health 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Conifer Health 2015 Population Health Management Business Region Distribution Analysis 8.4 Explorys 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Type I 8.4.2.2 Type II 8.4.2.3 Type III 8.4.3 Explorys 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Explorys 2015 Population Health Management Business Region Distribution Analysis 8.5 Health Catalyst 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Type I 8.5.2.2 Type II 8.5.2.3 Type III 8.5.3 Health Catalyst 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Health Catalyst 2015 Population Health Management Business Region Distribution Analysis 8.6 Healthagen 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Type I 8.6.2.2 Type II 8.6.2.3 Type III 8.6.3 Healthagen 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Healthagen 2015 Population Health Management Business Region Distribution Analysis 8.7 I2i Systems 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Type I 8.7.2.2 Type II 8.7.2.3 Type III 8.7.3 I2i Systems 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 I2i Systems 2015 Population Health Management Business Region Distribution Analysis 8.8 Mckesson 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Type I 8.8.2.2 Type II 8.8.2.3 Type III 8.8.3 Mckesson 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Mckesson 2015 Population Health Management Business Region Distribution Analysis 8.9 Phytel 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Type I 8.9.2.2 Type II 8.9.2.3 Type III 8.9.3 Phytel 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Phytel 2015 Population Health Management Business Region Distribution Analysis 8.10 Verisk Health 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Type I 8.10.2.2 Type II 8.10.2.3 Type III 8.10.3 Verisk Health 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Verisk Health 2015 Population Health Management Business Region Distribution Analysis 8.11 Wellcentive 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.2.1 Type I 8.11.2.2 Type II 8.11.2.3 Type III 8.11.3 Wellcentive 2015 Population Health Management Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 Wellcentive 2015 Population Health Management Business Region Distribution Analysis


The global accountable care solutions market is fragmented, with presence of many small companies which operate in their respective market segments. In this report global accountable care solutions market is segmented on basis of product and service, delivery mode, end users and regions. Healthcare provider solutions market accounted for the largest share of market in 2015 and covers electronic health /medical records, healthcare analytics, revenue cycle management, patient engagement solutions, population health management solutions, care management solutions, healthcare it integration systems, healthcare information exchange and clinical decision support systems. Full details on this report “Accountable Care Solutions Market” spread across 184 Pages, Profiling 11 Companies and Supported with 119 Tables and 51 Figures is now available at http://www.reportsnreports.com/reports/751486-accountable-care-solutions-market-by-product-service-ehr-healthcare-analytics-hie-rcm-cdss-population-health-claims-management-care-management-delivery-mode-on-premise-web-cloud-end-user-provider-st-to-2021.html Based on product and service, market is segmented into healthcare provider solutions, healthcare payer solutions and services. The accountable care solutions market is expected to grow at a lucrative CAGR of 16.6% from 2016 to 2021, to reach USD 18.86 billion by 2021 from USD 8.76 billion in 2016. Market growth can be attributed to the growing need to adhere to regulatory guidelines, government initiatives for eHealth, high return on investment (ROI), and rising needs to curtail escalating healthcare costs. On the other hand, lack of in-house IT domain knowledge and reluctance among end users to adopt new methods are expected to restrain the overall market growth to a certain extent during the forecast period. These small market players operating at regional- and local-levels are challenging the market share of leading players in this market. In order to maintain their market shares, leading players in market are continuously developing new technologies and upgrading their existing products to enhance their product portfolios. increasing competition is expected to drive innovation in market, thereby helping industry to overcome existing challenges in field of healthcare IT and at same time address compliance issues and unmet needs of market. Click Now for PDF Sample Download of this Study Report Geographically, North America is major market for accountable care solutions, accounting for 70% global market share, followed by Europe and Asia-Pacific. Asia-Pacific and Latin America possess lucrative growth potential for the accountable care solutions market during. This is mainly attributed to the extensive customer base in these regions due to large base of aging population, rising prevalence of various disorders increasing government initiatives for eHealth, rising medical tourism, and growing demand for quality healthcare in this region. The accountable care solutions market is fragmented in nature with the presence of many small and big firms. The major players in the accountable care solutions market include Cerner Corporation (U.S.), IBM Corporation (U.S.), UnitedHealth Group (U.S.), Aetna, Inc. (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Epic Systems Corporation (U.S.), Mckesson Corporation (U.S.), Verisk Health (U.S.), Zeomega, Inc. (U.S.), eClinical Works, Inc. (U.S.) and NextGen Healthcare (U.S.). Connect for More Details for Discount and More Information “Accountable Care Solutions Market by Product & Service (EHR, Healthcare Analytics, HIE, RCM, CDSS, Population Health, Claims Management, Care Management), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer) - Global Forecast to 2021” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=751486 . The study tracks and analyzes competitive developments such as partnerships, agreements, collaborations, alliances, mergers and acquisitions, new product developments, geographical expansions, and research and development activities and strategically profiles the key players and comprehensively analyze their market shares and core competencies in the accountable care solutions market. The accountable care solutions market in this report is segmented by product and service, delivery mode, end users, and regions.  It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). Explore more reports on Healthcare at http://www.reportsnreports.com/market-research/healthcare/ .


News Article | November 11, 2016
Site: www.prnewswire.co.uk

According to a new market research report "Accountable Care Solutions Market by Product & Service (EHR, Healthcare Analytics, HIE, RCM, CDSS, Population Health, Claims Management, Care Management), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer) - Global Forecast to 2021" published by MarketsandMarkets, The Accountable Care Solutions Market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 16.6% between 2016 and 2021 to reach USD 18.86 Billion by 2021. Browse 149 market data tables and 42 figures spread through 207 pages and in-depth TOC on "Accountable Care Solutions Market" Early buyers will receive 10% customization on this report. The growth of Accountable Care Solutions Market is mainly attributed to factors such as increasing government initiatives, implementation of initiatives to shift the burden of financial risk from payers to healthcare providers, growing need to curb healthcare costs and advancing IT and big data capabilities. The global Accountable Care Solutions Market is segmented on the basis of product and service, delivery mode, end users and regions. Based on product and service, the global Accountable Care Solutions Market is segmented into healthcare provider solutions, healthcare payer solutions and services. In 2015, healthcare provider solutions accounted for the largest share of the Accountable Care Solutions Market covers electronic health/medical records, healthcare analytics, revenue cycle management, patient engagement solutions, population health management solutions, care management solutions, healthcare it integration systems, healthcare information exchange and clinical decision support systems. This segment is also expected to witness the highest growth in the next five years. The growing need to improve the profitability of healthcare operations and government initiatives for eHealth implementation to improve the quality of care delivered to patients & curtail healthcare costs are the major drivers of market growth. The services segment is further classified into support & maintenance services, implementation services, consulting services, and training & education services. Furthermore, on the basis of end users, the market is classified into healthcare providers and healthcare payers. The healthcare provider's end user segment accounted for the largest share of accountable care solutions market. The growing need to improve the profitability of healthcare operations and government initiatives to improve the quality of care delivered to patients & curtail the soaring cost of healthcare are some of the factors driving the adoption of accountable care solutions among providers. In 2015, North America was the major market for accountable care solutions product and service, followed by Europe and Asia-Pacific. The highest market share of North America and European regions is primarily attributed to the presence and expansion of major healthcare IT companies through acquisitions which has improved the accessibility of accountable care solutions products and services in this region. However, Asia-Pacific and Latin American regions provide wide scope for the Accountable Care Solutions Market growth. This is mainly attributed to the continuous efforts of Asian economies toward the development of the healthcare sector in this region. These economies have modified regulations and monitored the implementation of procedures, policies, and guidelines to promote innovation and commercialization. This is attracting many homegrown entrepreneurs as well as global leaders to the region. The increasing number of hospitals, academic institutions, government focus to implement information technology in healthcare and improving healthcare infrastructure propel the market for accountable care solutions. Cerner Corporation (U.S.), IBM Corporation (U.S.), Aetna, Inc. (U.S.) and Epic Systems Corporation (U.S.) held the major share of the Accountable Care Solutions Market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are UnitedHealth Group (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), ckesson Corporation (U.S.), Verisk Health (U.S.), Zeomega, Inc. (U.S.), eClinicalWorks, Inc. (U.S.) and NextGen Healthcare (U.S.). Population Health Management Market by Component (Software, Services), by Delivery Mode (Web-based, Cloud-based), by End-User (Healthcare Providers, Healthcare Payers, Employer Groups) - Analysis & Global Forecasts to 2020 MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


WALTHAM, Mass.--(BUSINESS WIRE)--Verscend Technologies, Inc. (Verscend), a leader in data-driven healthcare solutions, today announced that the company’s President and CEO, Dr. Emad Rizk, will be presenting at the 26th annual Health Care Forecast Conference held at the UC Irvine Paul Merage School of Business in Irvine, Calif. on February 23-24. Dr. Rizk will participate in the “Disruptive Innovations in Health Care” session from 8 to 10 a.m. on February 24, and his presentation will focus on the impact of big data in healthcare and its effect on both payers and providers. Dr. Rizk will discuss how healthcare organizations can generate insights to deliver better care and better results at lower costs by harnessing enormous amounts of data, which will ultimately help to resolve the current financial healthcare crisis. “I am honored to speak at this leading national forum, where leaders from the government, business, and academic fields come together to discuss the economic and political issues that influence the healthcare industry,” said Dr. Emad Rizk, president and CEO of Verscend. “As an industry, healthcare has made tremendous strides with the innovative use of data. By leveraging the power of data, we can change the environment and dynamics of the market, impact interoperability, and manage new reimbursement models.” The Dean of UC Irvine Paul Merage School of Business, Dr. Eric Spangenberg, said, “This year’s Health Care Forecast Conference will focus on the future of healthcare under the new presidency. We are pleased to have Dr. Rizk and other industry leaders and authorities share expert insights on the outlook for healthcare in the United States. The speakers will address politics and policies amidst the ongoing challenges and continued debate in Congress over the Affordable Care Act.” About Verscend Technologies, Inc. Verscend Technologies (formerly Verisk Health) drives better healthcare outcomes through data analytics. Our payment accuracy, revenue integrity, risk assessment and stratification, and quality improvement solutions help organizations utilize their data so they can efficiently and cost-effectively succeed in the new era of healthcare. Learn more at www.verscend.com.


Ash A.S.,University of Massachusetts Medical School | Ash A.S.,Verisk Health | Ellis R.P.,Verisk Health | Ellis R.P.,Boston University
Medical Care | Year: 2012

Background: Many wish to change incentives for primary care practices through bundled population-based payments and substantial performance feedback and bonus payments. Recognizing patient differences in costs and outcomes is crucial, but customized risk adjustment for such purposes is underdeveloped. Research Design: Using MarketScan's claims-based data on 17.4 million commercially insured lives, we modeled bundled payment to support expected primary care activity levels (PCAL) and 9 patient outcomes for performance assessment. We evaluated models using 457,000 people assigned to 436 primary care physician panels, and among 13,000 people in a distinct multipayer medical home implementation with commercially insured, Medicare, and Medicaid patients. Methods: Each outcome is separately predicted from age, sex, and diagnoses. We define the PCAL outcome as a subset of all costs that proxies the bundled payment needed for comprehensive primary care. Other expected outcomes are used to establish targets against which actual performance can be fairly judged. We evaluate model performance using R's at patient and practice levels, and within policy-relevant subgroups. RESULTS:: The PCAL model explains 67% of variation in its outcome, performing well across diverse patient ages, payers, plan types, and provider specialties; it explains 72% of practice-level variation. In 9 performance measures, the outcome-specific models explain 17%-86% of variation at the practice level, often substantially outperforming a generic score like the one used for full capitation payments in Medicare: for example, with grouped R 2's of 47% versus 5% for predicting "prescriptions for antibiotics of concern." Conclusions: Existing data can support the risk-adjusted bundled payment calculations and performance assessments needed to encourage desired transformations in primary care. © 2012 by Lippincott Williams & Wilkins.


News Article | December 8, 2016
Site: www.businesswire.com

WALTHAM, Mass.--(BUSINESS WIRE)--Verscend Technologies, Inc. (Verscend), a leader in data-driven healthcare solutions, is celebrating the 20th anniversary of DxCG Intelligence (DxCG), one of the earliest and most accurate risk adjustment and predictive modeling solutions in the healthcare industry. Owned by Verscend, DxCG was foundational to the development of the Centers for Medicare and Medicaid Services’ (CMS) hierarchical condition categories (HCCs). Notably, DxCG, the industry standard, is the most complete set of risk adjustment and predictive models used by health plans, providers, employers, brokers, and consultants across the country. More than 140 models are grouped into three primary functional bundles—budgeting and underwriting, medical management, and performance assessment—and are tailored for commercial, Medicare, and Medicaid populations. DxCG risk-based predictive modeling has transformed the way healthcare is evaluated, delivered, and paid for, leading the way for value-based care initiatives across the United States. DxCG turns healthcare data into risk scores for individual patients and identifies primary drivers of risk. Scores correlate with the cost of the individual’s underlying illness burden. Aggregating the scores of patients with key attributes generates group-level predictive results that can help answer questions fundamental to managing clinical and financial risk. “For the past 20 years, DxCG has been a vital component of the healthcare industry,” said Dr. Emad Rizk, CEO of Verscend. “The benefits of DxCG are far-reaching, and include superior predictive power, robust models and applications, and broad utility making it a valuable tool for all constituents of the healthcare economy.” DxCG grew out of the federally funded academic research conducted by its founders, Arlene Ash, Randall Ellis, and Gregory Pope, who developed the hierarchical condition categories that the CMS uses for reimbursement today. The foundational role of accurate risk assessment has been recognized for decades, with risk adjustment and predictive modeling serving as cornerstones of modern value-based healthcare. The Society of Actuaries (SOA) recently published “Accuracy of Claims-Based Risk Scoring Models,” a study of commercial risk adjustment and predictive models. This study includes analysis of DxCG Intelligence models. Verscend has worked with the SOA to advance the science of risk scoring for the past 20 years, beginning with its 1996 paper, “Comparison of Risk Assessment Methods,” and extending to SOA’s first full study in 2007 and second full study in 2016. DxCG Intelligence has been evaluated in each of these studies. Once again, the DxCG models were top performers across the 2016 study, revalidating DxCG as an industry-pioneering risk scoring solution when it comes to longevity, depth of validation, breadth and scope of models, and model utility for population health management. To learn more about DxCG and its history, click here to read The Evolution of DxCG: The Gold Standard in Risk Adjustment and Predictive Modeling. Verscend Technologies (formerly Verisk Health) drives better healthcare outcomes through data analytics. Our payment accuracy, revenue integrity, risk assessment and stratification, and quality improvement solutions help organizations utilize their data so they can efficiently and cost-effectively succeed in the new era of healthcare. Learn more at www.verscend.com.

Loading Verisk Health collaborators
Loading Verisk Health collaborators